Journal Article

Molecular classification of primary breast tumors possessing distinct prognostic properties

Kyoko Iwao, Ryo Matoba, Noriko Ueno, Akiko Ando, Yasuo Miyoshi, Kenichi Matsubara, Shinzaburo Noguchi and Kikuya Kato

in Human Molecular Genetics

Volume 11, issue 2, pages 199-206
Published in print January 2002 | ISSN: 0964-6906
Published online January 2002 | e-ISSN: 1460-2083 | DOI: http://dx.doi.org/10.1093/hmg/11.2.199
Molecular classification of primary breast tumors possessing distinct prognostic properties

Show Summary Details

Preview

The natural progression of breast cancer differs greatly between patients; the precise prediction of this disease course will improve the efficacy of therapeutics. Gene expression profiling may elucidate the undiscovered biological variations between seemingly similar cancers, leading to a new cancer classification system valuable in accurate diagnosis. The expression levels of 2412 genes, derived from 98 cancer samples, were precisely recorded by a high throughput RT–PCR technique, adapter-tagged competitive PCR. Subsequent cluster analysis revealed a molecular profile, correlating with estrogen receptor levels and the presence of lymph node metastases. We analyzed 301 cancer samples for the expression patterns of 21 genes critical in this categorization. The classification of the samples into three major groups was verified utilizing principal component analysis. This molecular classification system correlated significantly with early recurrence, independent of lymph node status. This malignant potential is associated with the expression levels of a group of genes, which comprise a set of candidates potentially useful in diagnostic prediction. These genes and the associated control mechanisms may also be effective therapeutic targets.

Journal Article.  4325 words.  Illustrated.

Subjects: Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.